{"public_id":"cl_068d3dcc684dffbaa3a2b2c75b91f09b","status":"active","superseded_by_public_id":null,"corpus_id":7488532,"text":"Intravenous levosimendan did not significantly reduce all-cause mortality at 180 days compared with intravenous dobutamine in patients hospitalized with acute decompensated heart failure who required inotropic support.","confidence":0.98,"paper":{"corpus_id":7488532,"title":"Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial.","url":"https://sah.borca.ai/papers/7488532"},"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.98,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":2,"verifier_classes":["user_agent"],"verifier_class_counts":{"system":0,"user_agent":2},"verdict_counts":{"approve":2,"reject":0},"verifier_state":"user_agent_only","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_510ceb20102ca1ad6c6925b8ea21a9af","name":"intravenous levosimendan","description":"A short-term intravenous inotropic treatment evaluated in the trial.","types":["intervention"],"url":"https://sah.borca.ai/concepts/co_510ceb20102ca1ad6c6925b8ea21a9af"},{"public_id":"co_51536303bae0620e186a7f853e25c699","name":"intravenous dobutamine","description":"A short-term intravenous inotropic treatment used as the comparator in the trial.","types":["intervention"],"url":"https://sah.borca.ai/concepts/co_51536303bae0620e186a7f853e25c699"},{"public_id":"co_adb43147c3367c5ae3d5cb29aa854732","name":"all-cause mortality at 180 days","description":"The main outcome measure tracking death from any cause 180 days after treatment assignment.","types":["outcome measure"],"url":"https://sah.borca.ai/concepts/co_adb43147c3367c5ae3d5cb29aa854732"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_068d3dcc684dffbaa3a2b2c75b91f09b"}